Readers will likely be aware of the cross-jurisdictional litigation considering infringement by Samsung Bioepis / Amgen’s biosimilar eculizumab products of Alexion’s patent, EP 3 167 888 B1 (“EP 888…
On 18 July 2025, the Danish High Court (Eastern Division) rendered its decision on a matter concerning the medicinal product Dimethyl Fumarate (“DMF”) “Hexal” used in the treatment of multiple…
It has been a little over two years since the UPC issued its first order for provisional measures on 22 June 2023. The first year saw six preliminary injunctions (PIs) granted (two ex parte) out of…
Two recent patent decisions on opposite sides of the Atlantic - EcoFactor v. Google in the United States and Optis v. Apple in the United Kingdom - highlight a growing divergence in the role of…
It is well known that Artificial Intelligence (AI) is transforming industries worldwide, and with this transformation comes an increasing demand for patent protection. Although the examination of AI-…
The Brazilian Patent and Trademark Office (BRPTO/INPI) has recently opened a public consultation period (ending September 26, 2025) for proposed amendments to its Chemistry examination guidelines,…
In a recent decision by the Mannheim Local Division, the UPC granted the first-ever UPC injunction relating to the UK. This is a landmark decision following a number of preliminary judgments that…
The final week of July usually produces a flurry, and sometimes an avalanche, of decisions from the English Courts as Judges attempt to clear their desks before the holiday period. This year…
As discussed at length here, in T 56/21 3.3.04 came close to referring this issue to the Enlarged Board before getting cold feet. 3.3.02 have now taken up the gauntlet in T 697/22 and referred the…
Two years in, the UPC evokes less the exhilaration of a debut concert than the strange lethargy of Rammstein’s Keine Lust. In the iconic music video, the band arrives in full regalia, ready to play.…
